openPR Logo
Press release

Rapid Diagnostic Test Market Is Booming Across the Globe Explored in Latest Report 2019-2024 | Analysis by Key Players - Merck, GSK, Sanofi, Pfizer, Abbott

01-14-2020 11:58 AM CET | Health & Medicine

Press release from: Business Industry Reports

/ PR Agency: Business Industry Reports
Rapid Diagnostic Test (RDTs) Market

Rapid Diagnostic Test (RDTs) Market

This report provides in depth study of “Rapid Diagnostic Test (RDTs) Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Smart Home as a Service Market report also provides an in-depth survey of key players in the market organization.

Global Rapid Diagnostic Test (RDTs) Market overview:

BusinessIndustryReports have new report spread across 96 pages is an overview of the Global Rapid Diagnostic Test (RDTs) Market Report 2019. The Global Rapid Diagnostic Test (RDTs) Market is projected to grow at a healthy growth rate from 2019 to 2024 according to new research. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/230138.

The Rapid Diagnostic Test (RDTs) Market is expected to witness sustained growth over the forecast period (2019-2024). The growth of the Rapid Diagnostic Test (RDTs) market is driven as there is favourable growth in the industry is a major factor which will boost the global Rapid Diagnostic Test (RDTs) market. The global Rapid Diagnostic Test (RDTs) Market consists of a large pool of players. Vendors in this market are seen focusing on development of novel marketing strategies and ideas in order to carve a niche position for themselves.

The Global Rapid Diagnostic Test (RDTs) Market is segmented on the basis of Product Type, Application, End Use Industry and Region. On the Basis of Product Type segment, the Rapid Diagnostic Test (RDTs) Market is sub segmented into Digital RIDTs, Conventional RIDT. Based on End Use Industry segment, the Rapid Diagnostic Test (RDTs) Market is sub segmented into Hospitals & Clinics, Laboratori.

The Asia-Pacific region is projected to register a highest growth in the market between 2019 and 2024. The growing end-user industry is the key driver of the market in the region. Europe is projected to witness a slow growth during the forecast period due to stringent environment norms in the region. North America is the largest market for Rapid Diagnostic Test (RDTs) followed by Asia-Pacific. The increasing demand from the water treatment segment coupled with the rising demand from reviving Technology industry is driving the market for Rapid Diagnostic Test (RDTs) in North America.

Some of the Rapid Diagnostic Test (RDTs) Market manufacturers involved in the market are Merck, GSK, Sanofi, Pfizer, Abbott, Sekisui Diagnostics, Siemens Healthcare, Autoliv, Nippon Kayaku Group, Daicel Corporation, Hirtenberger , Acquisitions and effective mergers are some of the strategies adopted by the Rapid Diagnostic Test (RDTs) Market manufacturers. New product launches and continuous technological innovations are the Rapid Diagnostic Test (RDTs) Market strategies adopted by the major players.

Latest Industry Updates:

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ With or Without Papillary Tumors Who Are Ineligible for or Have Elected Not to Undergo Cystectomy

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy.

“Today’s approval of KEYTRUDA reinforces our company’s commitment to expanding existing treatment options for certain patients with high-risk, non-muscle invasive bladder cancer,” said Dr. Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories. “As the first anti-PD-1 therapy approved in this setting, KEYTRUDA will be a new clinical option for a patient population that previously had limited FDA-approved therapies available.”

Immune-mediated adverse reactions, which may be severe or fatal, can occur with KEYTRUDA, including pneumonitis, colitis, hepatitis, endocrinopathies, nephritis and renal dysfunction, severe skin reactions, solid organ transplant rejection, and complications of allogeneic hematopoietic stem cell transplantation (HSCT). Based on the severity of the adverse reaction, KEYTRUDA should be withheld or discontinued and corticosteroids administered if appropriate. KEYTRUDA can also cause severe or life-threatening infusion-related reactions. Based on its mechanism of action, KEYTRUDA can cause fetal harm when administered to a pregnant woman. For more information, see “Selected Important Safety Information” below.

Rapid Diagnostic Test (RDTs) Market: Region-wise Outlook

Asia Pacific was a prominent market for Rapid Diagnostic Test (RDTs)s in 2016. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income. Increased spending on home interiors is fuelling the Rapid Diagnostic Test (RDTs) market in Asia Pacific.

There are several manufacturers of Rapid Diagnostic Test (RDTs)s in Europe and North America. In North America, the demand for Rapid Diagnostic Test (RDTs)s is primarily driven by the residential sector. Improved standards of living and rising usage of Rapid Diagnostic Test (RDTs)s for flooring purpose are anticipated to drive the market in North America.

In Europe, the demand for Rapid Diagnostic Test (RDTs) is anticipated to be primarily from the commercial sector. Rapid Diagnostic Test (RDTs)s are being employed widely for flooring in commercial complexes, which is estimated be a major factor that is likely to propelling the consistent expansion of the Rapid Diagnostic Test (RDTs) market in the region.

Demand for Rapid Diagnostic Test (RDTs)s in Middle East & Africa is projected be primarily due to the utilization of Rapid Diagnostic Test (RDTs)s in the construction industry. In recent years, there has been exceptional growth in the construction industry of UAE and Egypt which has driven the market of Rapid Diagnostic Test (RDTs)s in the region of Middle East & Africa.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of HD Map in these regions, from 2013 to 2024 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Get Attractive Discount @ https://www.businessindustryreports.com/check-discount/230138.

Table of Contents:

1 Rapid Diagnostic Test (RDTs) Definition

2 Global Rapid Diagnostic Test (RDTs) Market Major Player Share and Market Overview

3 Major Player Rapid Diagnostic Test (RDTs) Business Introduction

4 Global Rapid Diagnostic Test (RDTs) Market Segmentation (Region Level)

5 Global Rapid Diagnostic Test (RDTs) Market Segmentation (Product Type Level)

6 Global Rapid Diagnostic Test (RDTs) Market Segmentation (Industry Level)

7 Global Rapid Diagnostic Test (RDTs) Market Segmentation (Channel Level)

8 Rapid Diagnostic Test (RDTs) Market Forecast 2019-2024

9 Rapid Diagnostic Test (RDTs) Segmentation Type

10 Rapid Diagnostic Test (RDTs) Segmentation Industry

11 Rapid Diagnostic Test (RDTs) Cost Analysis

12 Conclusion

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com 

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rapid Diagnostic Test Market Is Booming Across the Globe Explored in Latest Report 2019-2024 | Analysis by Key Players - Merck, GSK, Sanofi, Pfizer, Abbott here

News-ID: 1895678 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the